NDC 51662-1326-2 - 2% LIDOCAINE HCI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1326
- Requested NDC
- 51662-1326-2
- Package NDCs from labels
- 51662-1326-1, 51662-1326-2, 51662-1326-3
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 2% LIDOCAINE HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51662-1326-1 | 2020-02-07 | C162847 | 48780-1 | 9d75b9d0-90f7-f424-e053-dadaa90a57ce | 2% LIDOCAINE HCI INJECTION, USP 1000mg/50mL (20mg/mL) 50mL VIAL |
| 51662-1326-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-90f7-f424-e053-dadaa90a57ce | 2% LIDOCAINE HCI INJECTION, USP 1000mg/50mL (20mg/mL) 50mL VIAL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1326-1 | 2% LIDOCAINE HCI | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 7 | |
| 51662-1326-2 | 2% LIDOCAINE HCI | 1 mL in 1 POUCH | INJECTION, SOLUTION | 1 | 7 | |
| 51662-1326-3 | 2% LIDOCAINE HCI | 25 in 1 CASE | INJECTION, SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1326 | 2% LIDOCAINE HCI INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240130_78d8fb0a-bfae-6599-e053-2991aa0a2e03.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Burn Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HCI | Trifecta Pharmaceuticals USA LLC | 087ac43c-1076-d1e2-e063-6294a90a5859 | 2026-10-26 | Warnings | V13007Z41A |
| GuruNanda Pain Relief | LIDOCAINE HYDROCHLORIDE | GuruNanda, LLC. | 3ab6a133-8dca-e14e-e063-6394a90a85e7 | 2026-10-26 | Warnings | V13007Z41A |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Advagen Pharma Ltd | ae40021b-8df8-4b16-aac0-dcec88f76c7d | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Cardinal Health 107, LLC | 4e46cac7-00cd-4a01-ba11-9af4960cfbe9 | 2026-10-23 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | A-S Medication Solutions | 3b0282a6-9bfd-4052-b69c-2c68d488d009 | 2026-10-22 | Warnings, Adverse reactions | 1010033 V13007Z41A |
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| CVS Lidocaine Pain Relief | LIDOCAINE HYDROCHLORIDE, MENTHOL | CVS Pharmacy | 48c045ae-56b5-62c2-e063-6394a90aaf44 | 2026-10-22 | Warnings | V13007Z41A |
| Lidoryx 5% | LIDOCAINE HCL | Oncora Pharma, LLC | 38e82d76-2983-49cd-9248-95fbd0eec299 | 2026-10-22 | Warnings, Adverse reactions | V13007Z41A |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 89a4bd73-89f4-4fd7-2c9f-921e1da8f96b | 2026-10-20 | Warnings, Adverse reactions | V13007Z41A |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 3b2dd84e-cee8-4e58-d494-395a65a353a0 | 2026-10-19 | Warnings, Adverse reactions | ANDA088327 0409-4277 1737757 1737343 1010900 1010033 1737636 1737763 1010671 1737562 1737566 1737568 b9e7ccb4-f683-4267-aa5e-497a7250f39b 3b2dd84e-cee8-4e58-d494-395a65a353a0 V13007Z41A |
| Burn | LIDOCAINE HYDROCHLORIDE | J&A Digital Inc. | d4b09055-b93e-466f-9e24-cae098af6e24 | 2026-10-16 | Warnings | V13007Z41A |
| Lidocaine Viscous | LIDOCAINE HYDROCHLORIDE | A-S Medication Solutions | 75f2d450-aa2e-4a09-b4f7-4fcbcbf8b205 | 2026-10-13 | Boxed warning, Warnings, Adverse reactions | V13007Z41A |
| Burn Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HCI | Prostat First Aid | 5dc00980-1216-3bbd-e063-6294a90a0a02 | 2026-10-13 | Warnings | V13007Z41A |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Theraworx PM Nighttime Maximum Strength Pain Relief | LIDOCAINE HYDROCHLORIDE | AVADIM HOLDINGS, INC. | bc8cb476-9a47-47b3-ad78-a6ecec9ee66f | 2026-10-08 | Warnings | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.